Four patients in terminal renal failure who had various malignant tumours were treated by haemodialysis and cadaveric renal transplantation. One patient with a testicular seminoma and one with leiomyosarcomatous changes in polycystic kidneys were successfully grafted after removal of the tumours and both were healthy at three and two-and-a-half years afterwards without evidence of recurrence of tumour.
Introduction
The presence of any malignant disease in patients with terminal renal failure might be considered a contraindication to renal transplantation because of the possible danger of rapid disseminaftion in the presence of immunosuppressive drugs. We report here on four patients with malignant tumours who underwent renal transplantation.
Immunosuppressive Therapy All patients were treated with prednisolone and azathioprine. During rejection episodes the dose of prednisolone was increased to 200 mg/day for three days, gradually reducing to the previous level. Azathioprine was kept at the maximum level tolerated, as judged by leucocyte and thrombocyte counts, and 200 ,ug of actinomycin were given intravenously for three days. (Mitchinson et al., 1968 ).
An intravenous urogram showed gross dilatation of the right ureter and pelvis, which was presumed to be secondary to obstruction at the ureterovesical junction. This was reimplanted. The left kidney and ureter were not visualized, but retrograde pyelography showed a normal ureter with a small scarred and atrophic kidney. Blood urea was 75 mg/ 100 ml, creatinine clearance 54 mi/min, haemoglobin 12-2 g/100 ml, and E.S.R. 39 mmn/hr.
A course of postoperative radiotherapy to the para-aortic nodes was given, the kidneys and right testis being screened.
Renal function remained stable over the next year but steadily declined thereafter and he was admitted in terminal uraemia on 23 November 1970 when the level of blood urea was 332 mg/100 ml, creatinine 168 mg/100 ml, CO2 8 mEq/l., Na 146 mEq/l., K 5 mEq/l., Ca 6-1 mg/100 ml, P04 9 4 mg/100 ml, Case 4 A 56-year-old woman with polycystic disease of the kidneys and albinism went into terminal renal failure in October 1970. She was established on regular haemodialysis, and one month later bilateral nephrectomy and splenectomy were performed. The liver was noted to be polycystic. Eleven days later renal transplantation was performed and immunosuppression was started using steroids and azathioprine. Three days later the allograft had to be removed because of continued substantial heamorrhage from the operation site. Immunosuppressive drugs were withdrawn promptly and the patient was maintained on regular haemodialysis. Six months later a tender, firn, and enlarged lymphatic gland was noticed in the right femoral canal. She had had considerable shunt complications in the right leg before thfis and at first the enlarged gland was thought to be septic. At this time she complained of abdominal discomfort and epigastric distension, and a palpable tender hard mass was found in the epigastrium. Schneck and Penn (1971) reported 52 cases of "de novo" malignant namours in about 5,000 kidney and heart transplant patients throughout the world. Twenty-eight of these tumours were of epithelial origin and 24 were of mesenchymal origin, 11 being in the brain. The possibility of transplanting tumour tissue along with the allograft must always be considered, and living and cadaver donors should always be carefully screened. In Schneck and Penn's series it is possible that in two patients malignant tunours were present before transplantation, for metastatic spread developed very soon afterwards ).
Our patients had had malignant tumour before renal transplantation, and in such patients subsequent development of the tumour might be facilitated by immunosuppressive therapy.
It could, therefore, be argued that organ transplantation with subsequent immunosuppressive therapy has no place in the treatment of patients with cancer (Lancet, 1969) . Total hepatectomy for primary tumours and orthotopic liver transplantation has been performed, however, with encouraging success (Starzl et al., 1968; Calne, 1972) though tumour recurrences have been reported . In our series of liver transplants two patients who had primary malignant hepatomata were alive and well one year and six months after orthotopic transplantation with no evidence of recurrence. A third patient survived five years and had no evidence of malignant tumour when she died.
There have been very few reports of kidney transplantation in patients with previous neoplasia (Hume and Egdahl, 1955; Hume et al., 1963; Hume, 1968; Woodruff et al., 1969 ). Hume's two patients had Wilms's tumours, and both patients did well, but in one case where the time interval between removal of the tumour and transplantation was only six months tumour recurrence occurred two years later. In the other patient where the interval between tumour removal and transplantation was 12 years there was no evidence of recurrence. In the patient of Woodruff et al. (1969) with bilateral hypernephromata renal transplantation was performed a few days before the removal of the tumour. There was no evidence of metastases after four years (Woodruff, 1969) , but the patient eventually died of recurrent growth seven years after grafting (M. F. A. Woodruff, personal communication) .
Two of the patients reported here had malignant tumours of the kidneys, and transplantations were performed about two months after the removal of the tumours. In the two cases with non-renal rumours transplantation was performed two and three years after the removal of the primary tumours. In case 4 no information regarding the removal of the mole was availalble at the time of transplantation. The prognosis for stage I seminoma of the testis treated by orchidectomy and irradiation of para-aortic nodes approaches 90% survival (Peckham and McElwain, 1974) . The decision to proceed with transplantation in case 1 was therefore entirely justified.
Sarcomatous changes in polycystic kidneys are usually considered to be noninvasive and in case 2 they seemed to be confined entirely to the kidneys, but reports of distant metastases from such tumours have been found in the literature (Lowsley and Curtis, 1945; Borski and Kimrbrough, 1954; Roberts, 1973 ). These are rare tumours and though survival for five years after nephrectomy has been reported no information is available in regard to their prognosis.
The prognosis in patients with transitional cell carcinoma of the renal pelvis, even after removal, is poor, and when invasion of the renal substance and extrarenal structures has occurred the five-year survival rate is about 11°% (Williams and Mitchell, 1973) . The patient in case 3 enjoyed excellent health for eight months, but rapidly deteriorated and died within a few weeks with extensive metastases. It is difficult to assess the effect of renal transplantation and one week's immunosuppressive therapy in case 4. It is highly unlikely that she would have been considered for transplantation had the history of a previous melanotic tumour been known. and 15 asymptomatic abacteriuric patients with a previous history of frequency and dysuria.
Over a six-week period no difference in the Escherichia coli carriage rate was shown between these four groups. The carriage of all enterobacteria was slightly but significantly (P <0.05) lower in normal women compared with the patient groups but no difference was observed between the latter. There was no difference in the recovery rate and carriage of individual E. coli serotypes between the four groups.
It is concluded that the presence of enterobacteria or E. coli on the periurethral area is not the principal determinant factor in the pathogenesis of recurrent urinary tract infection or the urethral syndrome and that definition of carriage status is of little practical value in management.
